China Traditional Chinese Medicine Holdings Co. Limited
CHIZF
$0.275
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -7.53% | -6.80% | -12.78% | -14.10% | 3.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.53% | -6.80% | -12.78% | -14.10% | 3.41% |
| Cost of Revenue | 1.00% | 1.80% | -7.94% | -9.33% | 2.13% |
| Gross Profit | -15.66% | -14.99% | -17.41% | -18.66% | 4.67% |
| SG&A Expenses | -15.58% | -14.90% | -10.48% | -11.83% | 8.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 57.56% | 57.23% | 101.62% | 101.60% | -102.23% |
| Total Operating Expenses | -5.85% | -5.10% | -8.95% | -10.33% | 4.73% |
| Operating Income | -32.15% | -31.61% | -54.28% | -54.97% | -12.61% |
| Income Before Tax | -126.43% | -126.64% | -59.01% | -59.63% | 37.58% |
| Income Tax Expenses | 121.91% | 122.08% | -8.15% | -9.54% | -462.77% |
| Earnings from Continuing Operations | -124.91% | -125.11% | -66.41% | -66.92% | 156.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 150.37% | 150.77% | 91.99% | 92.11% | -238.92% |
| Net Income | -122.29% | -122.47% | -64.72% | -65.26% | 98.14% |
| EBIT | -32.15% | -31.61% | -54.28% | -54.97% | -12.61% |
| EBITDA | -16.47% | -15.80% | -33.92% | -34.92% | -7.07% |
| EPS Basic | -122.68% | -122.68% | -64.63% | -65.48% | 97.96% |
| Normalized Basic EPS | 0.00% | 0.00% | -56.14% | -55.93% | -40.00% |
| EPS Diluted | -122.68% | -122.68% | -64.63% | -65.48% | 97.96% |
| Normalized Diluted EPS | 0.00% | 0.00% | -56.14% | -55.93% | -40.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -1.00% |